Living with severe depression is incredibly hard, especially when standard intensive therapies do not provide the relief a person needs. A study of 234 adults looked at how mindfulness-based cognitive therapy (MBCT) compares to usual treatment for those who still have significant symptoms.
The researchers found that people starting with more severe symptoms saw greater improvements overall. Specifically, they looked at a skill called decentering. Decentering means learning to step back and view your thoughts as just passing events rather than facts about yourself. This mental shift helped reduce depressive symptoms over a 34-week period.
While the study shows that MBCT is effective for those with high symptom burdens, it is important to remember these results come from a secondary analysis of an existing trial. The data suggests that practicing decentering helps people distance themselves from their distress, making it a promising path for those seeking new ways to manage severe depression.
Common questions
What is mindfulness-based cognitive therapy?
Mindfulness-based cognitive therapy (MBCT) combines traditional cognitive therapy with mindfulness practices. It helps people learn to be present and observe their thoughts without judgment. In this study, it was compared to standard treatment for adults who did not find relief through high-intensity psychological therapy.
How does the concept of decentering help with depression?
Decentering is a skill where you learn to see your thoughts as just mental events rather than facts. The study found that this ability helped reduce depressive symptoms over 34 weeks. It was especially helpful for those who started with more severe symptoms, helping them distance themselves from their distress.
Who specifically can benefit from this type of therapy?
The study focused on adults who were not remitted after high-intensity psychological therapy. The results suggest that mindfulness-based cognitive therapy is particularly effective for individuals with a high symptom burden, meaning those experiencing more severe symptoms at the start of treatment.